{
  "id": "724250a4df4cdc5c",
  "title": "Tiziana Life Sciences submits annual safety report for intranasal foralumab to FDA",
  "description": "20251229T144500Z",
  "content": "",
  "source": "proactiveinvestors.com",
  "source_url": "https://www.proactiveinvestors.com/companies/news/1084993/tiziana-life-sciences-submits-annual-safety-report-for-intranasal-foralumab-to-fda-1084993.html",
  "published_at": "20251229T144500Z",
  "fetched_at": "2025-12-30T00:22:59.073919+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.proactiveinvestors.com/companies/news/1084993/tiziana-life-sciences-submits-annual-safety-report-for-intranasal-foralumab-to-fda-1084993.html",
    "url_mobile": "",
    "title": "Tiziana Life Sciences submits annual safety report for intranasal foralumab to FDA",
    "seendate": "20251229T144500Z",
    "socialimage": "https://cdn.proactiveinvestors.com/eyJidWNrZXQiOiJwYS1jZG4iLCJrZXkiOiJ1cGxvYWRcL05ld3NcL0ltYWdlXC8yMDI1XzEyXC8yMDIzLTAzLTI5LTA3LTMwLTM0LTZhYzAzNWY3NWYzOGQ4NTE2MDRmNWU5YjliNTYzMzllXzY5NTI4N2JkN2FkNjYuanBnIiwiZWRpdHMiOnsicmVzaXplIjp7IndpZHRoIjoxMjAwLCJoZWlnaHQiOjYzMCwiZml0IjoiY292ZXIifX19",
    "domain": "proactiveinvestors.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}